Found 6 matching trials
Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer PHASE2 The purpose of this study is to assess the effect of test doses of SPI-2012...
Show More Location
Arizona Center for Cancer Care
Learn More & Join Trial
A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy PHASE2 The purpose of this study is to evaluate the safety and pharmacokinetics of...
Show More Location
New York Medical College
Learn More & Join Trial
SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide PHASE3 The purpose of this study is to compare the efficacy of SPI-2012 versus peg...
Show More Location
ACRC/ Arizona Clinical Research Center Inc.
Learn More & Join Trial
SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE) PHASE3 The purpose of this study was to compare the efficacy of a single dose of S...
Show More Location
Arizona Center for Cancer Care
Learn More & Join Trial
Pharmacokinetics of SPI-2012 (Eflapegrastim) in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide (TC) Chemotherapy PHASE1 The purpose of this study is to evaluate the pharmacokinetic (PK) profile o...
Show More Learn More & Join Trial
Reducing Neutropenia Incidence With Pegfilgrastim Administration on Day 3 After Chemotherapy PHASE4 Patients who experienced neutropenia after receiving pegfilgrastim on day 1...
Show More Location
Good Gang-An Hospital
Learn More & Join Trial